<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01568905</url>
  </required_header>
  <id_info>
    <org_study_id>248</org_study_id>
    <nct_id>NCT01568905</nct_id>
  </id_info>
  <brief_title>Palatability of Experimental Cigarettes - Study 2</brief_title>
  <official_title>Palatability of Experimental Cigarettes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Smoking remains a leading cause of preventable disease and premature death worldwide.
      Approximately 1 out of every 5 deaths is associated with cigarette smoking, and roughly half
      of all daily smokers will die prematurely from tobacco-related illness. Reducing the nicotine
      in cigarettes to the point that they are rendered non-addictive can potentially be an
      effective public policy measure that can significantly reduce tobacco-related mortality and
      morbidity by decreasing the initiation of smoking and promoting cessation. The Family Smoking
      Prevention and Tobacco Control Act (FSPTCA) enables the FDA to establish tobacco product
      standards including placing limits on the allowable nicotine content of cigarettes.
      Currently, no reduced nicotine cigarettes are available that will allow studying the
      feasibility of this policy measure. The National Institute on Drug Abuse has contracted with
      Research Triangle Institute to assist in the development of cigarettes with varying nicotine
      content that can be made available to researchers. They have established a contract that will
      result in the manufacture of 9 million cigarettes to be distributed to the research
      community. Prior to full production, the palatability and nicotine intake of these cigarettes
      in smokers must be determined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase 3: This descriptive study will use a between subjects, double blind design. This study
      will test 3 nicotine levels of nicotine, tar and ventilation. Subjects and research
      assistants will be blind to the cigarette type.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in UrineTotal Nicotine Equivalent (TNE) Between Baseline and Week 1</measure>
    <time_frame>Second Visit (Week 1) minus Baseline (Day 1)</time_frame>
    <description>Two urine TNE levels are taken, one at baseline and one at week 1, to assess TNE levels for nicotine exposure. TNE is the sum of nicotine, cotinine, trans 3'-hydroxycotinine and their respective glucuronide conjugates. Values reported in nmols/ml.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Responses on Modified Cigarette Evaluation Scale</measure>
    <time_frame>Baseline usual brand cigarettes (Day 1) compared to when using study cigarettes (Week 1)</time_frame>
    <description>Modified Cigarette Evaluation Scale [CES] is a 100 mm visual analog scale (0=not at all or very little nicotine; 100=extremely or high in nicotine) of 20 questions assessing different dimensions of responses to usual brand cigarettes (e.g., psychological reward, satisfaction and aversiveness) and includes additional 5 point likert-type questions (definitely agree to definitely disagree) on perceptions of satisfaction and willingness to use the product. Results satisfaction subscale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline of Perceived Health Risk Scale Response to Test Cigarettes</measure>
    <time_frame>Baseline (Day 1) Compared to Second Visit (Week 1)</time_frame>
    <description>Questionnaire: Perceived Health Risk Scale asks subjects to rate their perception of health risks for lung cancer for the study product to which they have been randomly assigned. This is a 100 mm visual analog scale; 0=very low risk of disease, 100=very high risk of disease.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Number of Cigarettes Smoked</measure>
    <time_frame>1 week</time_frame>
    <description>Subjects were given a daily diary to collect the number of study and/or conventional cigarettes they have smoked each day. Cigarettes smoked (both usual brand and experimental) in a given week were summed over the first 7 reported days. If the number of cigarettes smoked was missing for 1 day, the average of the other days in that week was used in its place and reported as total number of cigarettes per week.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>Arm 1 Low Level Nicotine Cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(0.4 mg/g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 Intermediate Nicotine Level Cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(5.7-5.8 mg/g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3 High Level Nicotine Cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(11.4-12.8 mg/g)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low level nicotine cigarette</intervention_name>
    <description>smoke the study cigarette exclusively for one week</description>
    <arm_group_label>Arm 1 Low Level Nicotine Cigarette</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intermediate nicotine level cigarette</intervention_name>
    <description>smoke the study cigarette exclusively for one week</description>
    <arm_group_label>Arm 2 Intermediate Nicotine Level Cigarette</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High level nicotine cigarette</intervention_name>
    <description>smoke the study cigarette exclusively for one week</description>
    <arm_group_label>Arm 3 High Level Nicotine Cigarette</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-64 years old

          -  Regular smokers (10+ cigarettes per day and has done so for the last year)

          -  Inhaling when smoking

          -  Carbon monoxide (CO) &gt; 8 ppm

        Exclusion Criteria:

          -  In the past year, suffered from any cardiovascular disease such as: heart disease,
             heart attack, stroke or angina, any respiratory diseases such as chronic bronchitis or
             chronic obstructive pulmonary disease (COPD), any type of cancer

          -  Currently suffering from Bipolar Disorder, General Anxiety Disorder, Schizophrenia, or
             a major depressive episode

          -  Taken any of the following drugs more than twice per week during the past month:
             antidepressants, anti-anxiety medications.

          -  Consumed more than 15 alcoholic drinks per week for the past month

          -  Pregnant, trying to become pregnant, or lactating (assessed by self-report)

          -  In the past 3 months, used nicotine replacement products (like the patch, gum, or
             inhaler), or the medications bupropion varenicline

          -  Currently trying or planning to reduce or quit tobacco use in the next 30 days

          -  Used other forms of tobacco 10 or more days in the past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorothy Hatsukami, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tobacco Use Research Program, University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hatsukami DK, Heishman SJ, Vogel RI, Denlinger RL, Roper-Batker AN, Mackowick KM, Jensen J, Murphy SE, Thomas BF, Donny E. Dose-response effects of spectrum research cigarettes. Nicotine Tob Res. 2013 Jun;15(6):1113-21. doi: 10.1093/ntr/nts247. Epub 2012 Nov 22.</citation>
    <PMID>23178320</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2012</study_first_submitted>
  <study_first_submitted_qc>March 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2012</study_first_posted>
  <results_first_submitted>December 2, 2015</results_first_submitted>
  <results_first_submitted_qc>November 15, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 12, 2017</results_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>smoker</keyword>
  <keyword>smoking</keyword>
  <keyword>nicotine levels</keyword>
  <keyword>tobacco</keyword>
  <keyword>nicotine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm 1 Low Level Nicotine Cigarette</title>
          <description>Low level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="P2">
          <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
          <description>Intermediate nicotine level cigarette: smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="P3">
          <title>Arm 3 High Level Nicotine Cigarette</title>
          <description>High level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Daily cigarette smokers</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1 Low Level Nicotine Cigarette</title>
          <description>Low level nicotine cigarette (0.400 mg/g; menthol 0.405 mg/g): smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="B2">
          <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
          <description>Intermediate nicotine level cigarette (5.86 mg/g menthol 5.87 mg/g): smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="B3">
          <title>Arm 3 High Level Nicotine Cigarette</title>
          <description>High level nicotine cigarette (10.4 mg/g; menthol: 12.3): smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.0" spread="12.4"/>
                    <measurement group_id="B2" value="32.7" spread="10.8"/>
                    <measurement group_id="B3" value="43.6" spread="9.6"/>
                    <measurement group_id="B4" value="37.9" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Menthol</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Menthol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non Menthol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cigarettes per day</title>
          <units>Cigarettes per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.8" spread="5.1"/>
                    <measurement group_id="B2" value="16.1" spread="3.5"/>
                    <measurement group_id="B3" value="18.7" spread="4.3"/>
                    <measurement group_id="B4" value="17.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in UrineTotal Nicotine Equivalent (TNE) Between Baseline and Week 1</title>
        <description>Two urine TNE levels are taken, one at baseline and one at week 1, to assess TNE levels for nicotine exposure. TNE is the sum of nicotine, cotinine, trans 3'-hydroxycotinine and their respective glucuronide conjugates. Values reported in nmols/ml.</description>
        <time_frame>Second Visit (Week 1) minus Baseline (Day 1)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Low Level Nicotine Cigarette</title>
            <description>Low level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
            <description>Intermediate nicotine level cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 High Level Nicotine Cigarette</title>
            <description>High level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Change in UrineTotal Nicotine Equivalent (TNE) Between Baseline and Week 1</title>
          <description>Two urine TNE levels are taken, one at baseline and one at week 1, to assess TNE levels for nicotine exposure. TNE is the sum of nicotine, cotinine, trans 3'-hydroxycotinine and their respective glucuronide conjugates. Values reported in nmols/ml.</description>
          <units>nmols/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-16.2" spread="5.0"/>
                    <measurement group_id="O2" value="-7.6" spread="4.7"/>
                    <measurement group_id="O3" value="1.3" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Responses on Modified Cigarette Evaluation Scale</title>
        <description>Modified Cigarette Evaluation Scale [CES] is a 100 mm visual analog scale (0=not at all or very little nicotine; 100=extremely or high in nicotine) of 20 questions assessing different dimensions of responses to usual brand cigarettes (e.g., psychological reward, satisfaction and aversiveness) and includes additional 5 point likert-type questions (definitely agree to definitely disagree) on perceptions of satisfaction and willingness to use the product. Results satisfaction subscale.</description>
        <time_frame>Baseline usual brand cigarettes (Day 1) compared to when using study cigarettes (Week 1)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Low Level Nicotine Cigarette</title>
            <description>Low level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
            <description>Intermediate nicotine level cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 High Level Nicotine Cigarette</title>
            <description>High level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Responses on Modified Cigarette Evaluation Scale</title>
          <description>Modified Cigarette Evaluation Scale [CES] is a 100 mm visual analog scale (0=not at all or very little nicotine; 100=extremely or high in nicotine) of 20 questions assessing different dimensions of responses to usual brand cigarettes (e.g., psychological reward, satisfaction and aversiveness) and includes additional 5 point likert-type questions (definitely agree to definitely disagree) on perceptions of satisfaction and willingness to use the product. Results satisfaction subscale.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.8" spread="4.1"/>
                    <measurement group_id="O2" value="54.1" spread="4.1"/>
                    <measurement group_id="O3" value="61.4" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline of Perceived Health Risk Scale Response to Test Cigarettes</title>
        <description>Questionnaire: Perceived Health Risk Scale asks subjects to rate their perception of health risks for lung cancer for the study product to which they have been randomly assigned. This is a 100 mm visual analog scale; 0=very low risk of disease, 100=very high risk of disease.</description>
        <time_frame>Baseline (Day 1) Compared to Second Visit (Week 1)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Low Level Nicotine Cigarette</title>
            <description>Low level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
            <description>Intermediate nicotine level cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 High Level Nicotine Cigarette</title>
            <description>High level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline of Perceived Health Risk Scale Response to Test Cigarettes</title>
          <description>Questionnaire: Perceived Health Risk Scale asks subjects to rate their perception of health risks for lung cancer for the study product to which they have been randomly assigned. This is a 100 mm visual analog scale; 0=very low risk of disease, 100=very high risk of disease.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.6" spread="4.6"/>
                    <measurement group_id="O2" value="66.7" spread="4.6"/>
                    <measurement group_id="O3" value="68.3" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of Number of Cigarettes Smoked</title>
        <description>Subjects were given a daily diary to collect the number of study and/or conventional cigarettes they have smoked each day. Cigarettes smoked (both usual brand and experimental) in a given week were summed over the first 7 reported days. If the number of cigarettes smoked was missing for 1 day, the average of the other days in that week was used in its place and reported as total number of cigarettes per week.</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1 Low Level Nicotine Cigarette</title>
            <description>Low level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O2">
            <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
            <description>Intermediate nicotine level cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
          <group group_id="O3">
            <title>Arm 3 High Level Nicotine Cigarette</title>
            <description>High level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Number of Cigarettes Smoked</title>
          <description>Subjects were given a daily diary to collect the number of study and/or conventional cigarettes they have smoked each day. Cigarettes smoked (both usual brand and experimental) in a given week were summed over the first 7 reported days. If the number of cigarettes smoked was missing for 1 day, the average of the other days in that week was used in its place and reported as total number of cigarettes per week.</description>
          <units>cigarettes per week</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" spread="15.9"/>
                    <measurement group_id="O2" value="112.8" spread="49.4"/>
                    <measurement group_id="O3" value="157.6" spread="15.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 week</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1 Low Level Nicotine Cigarette</title>
          <description>Low level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="E2">
          <title>Arm 2 Intermediate Nicotine Level Cigarette</title>
          <description>Intermediate nicotine level cigarette: smoke the study cigarette exclusively for one week</description>
        </group>
        <group group_id="E3">
          <title>Arm 3 High Level Nicotine Cigarette</title>
          <description>High level nicotine cigarette: smoke the study cigarette exclusively for one week</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dorohty Hatsukami, Ph.D.</name_or_title>
      <organization>University of Minnesota Tobacco Research Programs</organization>
      <phone>612-626-2121</phone>
      <email>hatsu001@umn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

